BioSpace News Archive

Nicox SA, an international ophthalmology company, announced that its exclusive Chinese partner, Ocumension Therapeutics, has submitted a New Drug Application for approval to commercialize ZERVIATE®, 0.24%, in China, for ocular itching associated with allergic conjunctivitis.

Hansa Biopharma AB will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023.

OncoOne, a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced two poster presentations highlighting new preclinical data from its oxMIF-targeting drug candidate pipeline at the upcoming American Association for Cancer Research Annual Meeting 2023, held from April 14-19, in Orlando, Florida.

Zura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the appointment of Michael D. Howell, Ph.D., to the role of Chief Scientific Officer and Head of Translational Science.